Titan Pharmaceuticals announces pricing of $9.0 million underwritten public offering
Titan Pharmaceuticals announced pricing of an underwritten public offering of 40,000,000 units at a price to the public of $0.225 per unit. Each unit issued in the offering consists of one share of common stock and one Class B Warrant to purchase one share of common stock. October 16, 2019